Abstract
Immunotherapy in pancreatic ductal adenocarcinoma (PDAC) treatment faces serious challenges, due particularly to the poor immunogenicity of PDAC. Cancer cell-derived exosomes play important roles in damaging the immune system. However, the effects of pancreatic cancer-derived exosomes on T lymphocytes are unknown. Here we investigated changes in phenotypes and signal transduction pathways in exosomes-treated T lymphocytes. We identified the overexpression of immune checkpoint proteins PD-1, PD-L1, CTLA4, and Tim-3, and the enrichment of FOXP3 + Treg cluster in exosomes-treated T lymphocytes by CyTOF. RNA-sequencing and Gene Set Enrichment Analysis revealed that DNA damage response and metabolic pathways might be involved in exosomes-induced Tregs. ATM, AMPK, SIRT1, SIRT2, and SIRT6 were activated sequentially in exosomes-treated T lymphocytes and essential for exosomes-upregulated expressions of FOXO1A, FOXO3A and FOXP3. Our study reveals the impact and mechanism of pancreatic cancer cell-derived exosomes on T lymphocytes and may provide insights into developing immunotherapy strategies for PDAC treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
